Philippine FDA to Ban Flavored E-Cigarette Products in 2022

May.26.2022
Effective May 25, 2022, Philippines FDA will prohibit flavored e-cigarettes and additives besides regular tobacco or menthol.

The Philippine Food and Drug Administration (FDA) has announced to all stakeholders, government agencies, and the public that effective May 25, 2022, the manufacturing, trading, distribution, importation, wholesale, retail, and online retail/wholesale of flavored electronic cigarette liquids will no longer be permitted.

 

According to Republic Act No. 11467 and its implementing rules and regulations, the manufacture, trade, distribution, importation, wholesale, retail, and online sale or wholesale of flavored electronic cigarette products (ECPs) other than ordinary tobacco or ordinary menthol are prohibited.

 

Furthermore, as stated in Executive Order 106, it should be prohibited to add electronic cigarette liquids that have been proven or suspected to be attractive or enticing to individuals under the age of twenty-one (21), toxic, harmful, addictive, or allergenic.

 

If you have any questions or inquiries, please contact CCHUHSRR at (02) 857-1900 local 8107 or 8113, or through email at ntru@fda.gov.ph.

 

Click to download: FDA Announcement Number 2022-1069.

 

Source: Philippine Food and Drug Administration

 

Please refer to official sources for accurate information.

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Tunisia's tobacco control policies are insufficiently implemented; experts call for the introduction of less harmful alternatives to help quit smoking
Tunisia's tobacco control policies are insufficiently implemented; experts call for the introduction of less harmful alternatives to help quit smoking
Although Tunisia has joined the WHO Framework Convention on Tobacco Control and implemented policies such as smoking bans and advertising restrictions, insufficient enforcement means nearly half of all men still smoke, with youth being particularly vulnerable. Public health experts recommend that Tunisia learn from the experiences of Sweden and the United Kingdom, introduce less harmful alternatives, and establish a customized regulatory system.
Sep.30 by 2FIRSTS.ai
Product | VOZOL Launches Two SLEEK-Series Devices Compatible with Mesh and Ceramic Coils
Product | VOZOL Launches Two SLEEK-Series Devices Compatible with Mesh and Ceramic Coils
VOZOL expands its SLEEK line with the SLEEK VISION e-cigarette, which uses the same series pods and supports both mesh and ceramic coils. SLEEK VISION features a boxier design with a 0.99-inch display for battery level and mode, and upgrades the battery to 900 mAh (vs. 600 mAh on SLEEK).
Nov.11 by 2FIRSTS.ai
Juul Wins UK Court Injunction, Ending Five-Year Legal Battle Against Chinese Vape Infringers
Juul Wins UK Court Injunction, Ending Five-Year Legal Battle Against Chinese Vape Infringers
The UK High Court has granted U.S. e-cigarette manufacturer Juul Labs a permanent injunction against four Chinese companies, bringing an end to a five-year patent and trademark infringement case. The defendants — Greensun Technology, Ouch, Gaish, and Airsmo Tech — failed to respond to any court communications or legal filings.
Oct.30 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
JTI UK Expands Nordic Spirit Line, Launches 17mg Nicotine Pouch
JTI UK Expands Nordic Spirit Line, Launches 17mg Nicotine Pouch
JTI UK has launched Nordic Spirit’s highest-strength variant—Frosty Mint Max, delivering 17mg of nicotine per pouch—and introduced a refreshed, darker packaging design for the brand.
Oct.31 by 2FIRSTS.ai
2Firsts Feature | The “Pink Tax” in Vaping: How Women-Centric Design and Pricing Are Recasting the Competitive Landscape
2Firsts Feature | The “Pink Tax” in Vaping: How Women-Centric Design and Pricing Are Recasting the Competitive Landscape
Overseas e-cig brands are embracing “for her” designs, turning devices into fashion accessories. 2Firsts notes a new “pink tax” emerging through design and pricing, reflecting shifting gender and branding strategies.
Oct.20